http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111601797-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725 |
| filingDate | 2019-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111601797-B |
| titleOfInvention | Benzopiperidine or heteroaryl piperidine derivatives, their preparation method and their application in medicine |
| abstract | The present invention relates to benzopiperidine or heteroaryl piperidine derivatives, their preparation method and their application in medicine. In particular, the present invention relates to benzopiperidine derivatives or heteroaryl piperidine derivatives represented by the general formula (I), their preparation methods and pharmaceutical compositions containing the derivatives, and as estrogens Use of a receptor modulator for the prevention and/or treatment of an estrogen receptor mediated or dependent disease or condition, said disease being particularly preferably breast cancer. Wherein the substituents in the general formula (I) are the same as defined in the description. |
| priorityDate | 2018-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 228.